Literature DB >> 22079093

Proteomic analysis of the 20S proteasome (PSMA3)-interacting proteins reveals a functional link between the proteasome and mRNA metabolism.

Olga A Fedorova1, Tatiana N Moiseeva, Andrey A Nikiforov, Anna S Tsimokha, Veronika A Livinskaya, Mark Hodson, Andrew Bottrill, Irina N Evteeva, Julia B Ermolayeva, Irina M Kuznetzova, Konstantin K Turoverov, Ian Eperon, Nickolai A Barlev.   

Abstract

The 26S proteasome is a large multi-subunit protein complex that exerts specific degradation of proteins in the cell. The 26S proteasome consists of the 20S proteolytic particle and the 19S regulator. In order to be targeted for proteasomal degradation most of the proteins must undergo the post-translational modification of poly-ubiquitination. However, a number of proteins can also be degraded by the proteasome via a ubiquitin-independent pathway. Such degradation is exercised largely through the binding of substrate proteins to the PSMA3 (alpha 7) subunit of the 20S complex. However, a systematic analysis of proteins interacting with PSMA3 has not yet been carried out. In this report, we describe the identification of proteins associated with PSMA3 both in the cytoplasm and nucleus. A combination of two-dimensional gel electrophoresis (2D-GE) and tandem mass-spectrometry revealed a large number of PSMA3-bound proteins that are involved in various aspects of mRNA metabolism, including splicing. In vitro biochemical studies confirmed the interactions between PSMA3 and splicing factors. Moreover, we show that 20S proteasome is involved in the regulation of splicing in vitro of SMN2 (survival motor neuron 2) gene, whose product controls apoptosis of neurons.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079093     DOI: 10.1016/j.bbrc.2011.10.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.

Authors:  Alexey G Mittenberg; Tatyana N Moiseeva; Valeria O Kuzyk; Nickolai A Barlev
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

2.  Simultaneous EGFP and tag labeling of the β7 subunit for live imaging and affinity purification of functional human proteasomes.

Authors:  Valentina A Kulichkova; Tatiana O Artamonova; Julia J Zaykova; Julia B Ermolaeva; Mikhail A Khodorkovskii; Nikolai A Barlev; Alexey N Tomilin; Anna S Tsimokha
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

3.  Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.

Authors:  Ekaterina Lomert; Lidia Turoverova; Daria Kriger; Nikolai D Aksenov; Alina D Nikotina; Alexey Petukhov; Alexey G Mittenberg; Nikolai V Panyushev; Mikhail Khotin; Kirill Volkov; Nikolai A Barlev; Dmitri Tentler
Journal:  Cell Cycle       Date:  2018-01-22       Impact factor: 4.534

4.  Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.

Authors:  Olga Fedorova; Alexey Petukhov; Alexandra Daks; Oleg Shuvalov; Tatyana Leonova; Elena Vasileva; Nikolai Aksenov; Gerry Melino; Nikolai A Barlev
Journal:  Oncogene       Date:  2018-11-19       Impact factor: 9.867

5.  Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

Authors:  Alexey G Mittenberg; Valeria O Kuzyk; Sergey V Shabelnikov; Daria P Gorbach; Alla N Shatrova; Olga A Fedorova; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

6.  Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis.

Authors:  Olga Fedorova; Alexandra Daks; Varvara Petrova; Alexey Petukhov; Larissa Lezina; Oleg Shuvalov; Pavel Davidovich; Darya Kriger; Ekaterina Lomert; Dmitry Tentler; Victor Kartsev; Burhan Uyanik; Vyacheslav Tribulovich; Oleg Demidov; Gerry Melino; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-09-05       Impact factor: 4.534

Review 7.  Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.

Authors:  Ivano Amelio; Vivien Landré; Richard A Knight; Andrey Lisitsa; Gerry Melino; Alexey V Antonov
Journal:  Oncotarget       Date:  2015

8.  miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.

Authors:  L Lezina; N Purmessur; A V Antonov; T Ivanova; E Karpova; K Krishan; M Ivan; V Aksenova; D Tentler; A V Garabadgiu; G Melino; N A Barlev
Journal:  Cell Death Dis       Date:  2013-12-12       Impact factor: 8.469

9.  Human EHMT2/G9a activates p53 through methylation-independent mechanism.

Authors:  M Rada; E Vasileva; L Lezina; D Marouco; A V Antonov; S Macip; G Melino; N A Barlev
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

10.  The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.

Authors:  Alexandra Daks; Alexey Petukhov; Olga Fedorova; Oleg Shuvalov; Alena Kizenko; Elizaveta Tananykina; Elena Vasileva; Oleg Semenov; Andrew Bottrill; Nickolai Barlev
Journal:  Cell Death Dis       Date:  2021-06-05       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.